GlaxoSmithKline Contract Details

Defense contract under the Defense Logistics Agency awarded to GlaxoSmithKline on 6/8/2016.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: GlaxoSmithKline
Department: Defense Logistics Agency
Awarded: 6/8/2016

GlaxoSmithKline, Research Triangle Park, North Carolina, has been awarded a maximum $17,115,211 firm-fixed-price, indefinite-quantity contract for multi-dose influenza vaccine vials. This is a one-year contract with no option years. This was a competitive acquisition with four responses received. Location of performance is North Carolina, with a June 7, 2017, performance completion date. Using services are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is fiscal 2016 through fiscal 2017 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-16-D-0006).

Total Contract Value: $17,115,211

View all contracts that include "GlaxoSmithKline" in the MiC database.